Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial-Reference-Cited by-同舟云学术

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial

Published:2015-09-28 Issue:2 Volume:23 Page:105-115
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Stahmeyer J. T.¹,Krauth C.¹,Bert F.²,Pfeiffer-Vornkahl H.³,Alshuth U.⁴,Hüppe D.⁵,Mauss S.⁶,Rossol S.²

Affiliation:

1. Institute for Epidemiology; Social Medicine and Health Systems Research; Hannover Medical School; Hannover Germany

2. Department of Internal Medicine; Krankenhaus Nordwest; Frankfurt/M Germany

3. Factum - Company for Statistics; Scientific Information and Communication mbH; Offenbach Germany

4. Virology; Roche Pharma AG; Grenzach-Wyhlen Germany

5. Center of Gastroenterology; Herne Germany

6. Center for HIV and Hepatogastroenterology; Duesseldorf Germany

Funder

Janssen, Roche Pharma AG

Boehringer

Janssen

Roche Pharma AG

Gilead Sciences

Bristol-Myers-Squibb

Novartis

Meso Scale Diagnostics

Janssen-Cilag

AbbVie

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12471/fullpdf

Reference58 articles.

1. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

2. Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1);Poethko-Muller;Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,2013

3. Epidemiology of chronic hepatitis C in Germany-an analysis of 10,326 patients in hepatitis centres and outpatient units;Huppe;Z Gastroenterol,2008

4. High prevalence of anti-HCV antibodies in two metropolitan emergency departments in Germany: a prospective screening analysis of 28,809 patients;Vermehren;PLoS ONE,2012

5. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression;Thein;Hepatology,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R);Zeitschrift für Gastroenterologie;2022-07-15

2. Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents;Journal of Occupational Medicine and Toxicology;2021-08-24

3. Effects of Different Direct Acting Antivirals on Quality of life of Patients with Chronic Hepatitis C;Mediterranean Journal of Infection Microbes and Antimicrobials;2021-02-24

4. Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany;International Journal of Environmental Research and Public Health;2020-01-09

5. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus;Medical Care;2019-04